文献速递流行病学与生物统计

外科随机对照试验安慰剂组应答时间变化的Meta分析:更新版

A meta-analysis of temporal changes of response in the placebo arm of surgical randomized controlled trials: an update.
PubMed 文献 · Trials · 2017-07-12

该更新版系统综述与Meta分析纳入47项外科随机对照试验,用线性混合效应模型分析安慰剂组应答随时间及访视次数的变化。结果显示安慰剂组总体应答不随时间或访视次数变化,主观结局的应答较大且相对恒定,客观结局的应答较小但随时间减弱;评估结局的试验因研究数少和临床异质性高需谨慎解读。

要点

  • 47项试验中安慰剂组应答不随时间(β=-0.0070)或访视次数(β=-0.033)变化。
  • 主观结局安慰剂组应答较大(β0=0.68)且随时间相对恒定。
  • 客观结局安慰剂组应答较小(β0=0.28)但随时间减弱(β=-0.030)。

核心结论

  • 结果与既往发现一致,主观结局的安慰剂组应答较大且至少一年内相对恒定。
  • 单次侵入性操作的安慰剂效应值得关注,时间与访视次数对主观结局无影响引发对安慰剂效应或偏倚的进一步疑问。

研究设计与样本

  • 该系统综述与Meta分析的更新版共纳入47项外科随机对照试验。
  • 采用线性混合效应模型分析试验内相关性,考察评估时间和访视次数对安慰剂组基线变化幅度的影响。

主要发现

  • 全部47项试验中,安慰剂组应答幅度不随时间(β=-0.0070,95%CI -0.024至0.010)或访视次数(β=-0.033,95%CI -0.082至0.017)变化,且至少12个月或7次随访访视时仍显著不同于基线。
  • 主观结局试验中,安慰剂组变化较大(β0=0.68,95%CI 0.53至0.82),且随时间(β=-0.0042,95%CI -0.024至0.016)和访视次数(β=-0.029,95%CI -0.089至0.031)相对恒定。
  • 客观结局试验中,应答较小(β0=0.28,95%CI 0.11至0.46)并随时间减弱(β=-0.030,95%CI -0.050至-0.010),但不随访视次数变化(β=-0.099,95%CI -0.30至0.11)。
  • 评估结局的试验中,时间(β=-0.0071,95%CI -0.026至0.011)或访视次数(β=-0.032,95%CI -0.33至0.26)无显著效应,但研究数少且研究间临床异质性高,结果需谨慎解读。
  • 以疼痛为结局的试验中,改善显著(β0=0.91,95%CI 0.75至1.07),但时间(β=-0.013,95%CI -0.06至0.03)或访视次数(β=-0.045,95%CI -0.16至0.069)无效应,疼痛评分在12个月或7次访视时仍显著不同于基线。

局限性

  • 评估结局的试验结果因研究数少和研究间临床异质性高需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Temporal changes in the placebo arm of randomized controlled trials (RCTs) have not been thoroughly investigated, despite the fact that results of RCTs depend on the comparison between arms. METHODS: In this update of our earlier systematic review and meta-analysis, we set out to investigate the effect of assessment time and number of visits on the magnitude of change from baseline in the placebo arm of these trials. We used linear mixed-effects models to account for within-trial correlations. RESULTS: Across all 47 trials the magnitude of response in the placebo arm did not change with time (β = -0.0070, 95% CI -0.024, 0.010) or visit (β = -0.033, 95% CI -0.082, 0.017) and remained significantly different from baseline for at least 12 months or seven follow-up visits. Change in the placebo arm in trials with subjective outcomes was large (β0 = 0.68, 95% CI 0.53, 0.82) and relatively constant across time (β = -0.0042, 95% CI -0.024, 0.016) and visit (β = -0.029, 95% CI -0.089, 0.031), whereas in trials with objective outcomes the response was smaller (β0 = 0.28, 95% CI 0.11, 0.46) and diminished with time (β = -0.030, 95% CI -0.050, -0.010), but not with visit (β = -0.099, 95% CI -0.30, 0.11). For trials with assessed outcomes, there was no significant effect of time (β = -0.0071, 95% CI -0.026, 0.011) or visit (β = -0.032, 95% CI -0.33, 0.26); however, these results should be interpreted with caution due to the small number of studies, and high clinical heterogeneity between studies. In trials with pain as an outcome, the improvement was significant (β0 = 0.91, 95% CI 0.75, 1.07), but there was no effect of time (β = -0.013, 95% CI -0.06, 0.03) or visit (β = -0.045, 95% CI -0.16, 0.069), and pain ratings remained significantly different from baseline for 12 months or seven visits. CONCLUSIONS: These results are consistent with our previous findings. In trials with subjective outcomes response in the placebo arm remains large and relatively constant for at least a year, which is interesting considering that this is an effect of a single application of an invasive procedure. The lack of effect of time and visit number on subjective outcomes raises further questions regarding whether the observed response is the result of placebo effect or the result of bias.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wartolowska KA, Gerry S, Feakins BG, et al. A meta-analysis of temporal changes of response in the placebo arm of surgical randomized controlled trials: an update. Trials. 2017. PMID: 28701195. doi:10.1186/s13063-017-2070-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。